https://www.selleckchem.com/pr....oducts/abraxane-nab-
ists for additional study in a RCT setting with close monitoring and reporting of SDC to better inform clinical practice.Breast cancer survivors have a high risk of a second primary contralateral breast cancer (CBC), but there are few studies of CBC risk in racial/ethnic minority populations. We examined whether the incidence and risk factors for CBC differed by race/ethnicity in the United States. Women with a first invasive Stage I-IIB breast cancer diagnosis at ages 20-74 years between 2000 and 2015 in the Surveillanc
Beğen
Yorum Yap
Paylaş
